Efficacy of Infliximab Dose Escalation in Patients with Refractory Immunotherapy-Related Colitis: A Case Series

被引：3

作者：

Harris, Jessica P. ^{[1
]}

Postow, Michael A. ^{[2
,3
]}

Faleck, David M. ^{[1
,3
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, Gastroenterol Hepatol & Nutr Serv, 1275 York Ave, New York, NY 10065 USA

[2] Weill Cornell Med Coll, Mem Sloan Kettering Canc Ctr, Melanoma Serv, New York, NY USA

[3] Weill Cornell Med Coll, New York, NY USA

来源：

ONCOLOGIST | 2022年 / 27卷 / 04期

基金：

美国国家卫生研究院;

关键词：

D O I：

10.1093/oncolo/oyac019

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Immune checkpoint inhibitor-related colitis is a common complication of immunotherapy use in patients with cancer. Current guidelines recommend treatment with standard dose infliximab (IFX) for corticosteroid-refractory colitis; however, this case series suggests IFX dose escalation may be a viable treatment option for refractory cases.

引用

页码：E350 / E352

页数：3

共 10 条

[1] Outcomes of vedolizumab therapy in patients with immune checkpoint inhibitor-induced colitis: a multi-center study [J].

Abu-Sbeih, Hamzah ;

Ali, Faisal S. ;

Alsaadi, Dana ;

Jennings, Joseph ;

Luo, Wenyi ;

Gong, Zimu ;

Richards, David M. ;

Charabaty, Aline ;

Wang, Yinghong .

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2018, 6

[2] Systematic Review and Meta-analysis: Optimal Salvage Therapy in Acute Severe Ulcerative Colitis [J].

Choy, Matthew C. ;

Seah, Dean ;

Faleck, David M. ;

Shah, Shailja C. ;

Chao, Che-Yung ;

An, Yoon-Kyo ;

Radford-Smith, Graham ;

Bessissow, Talat ;

Dubinsky, Marla C. ;

Ford, Alexander C. ;

Churilov, Leonid ;

Yeomans, Neville D. ;

De Cruz, Peter P. .

INFLAMMATORY BOWEL DISEASES, 2019, 25 (07) :1169-1186

[3] Infliximab in acute severe colitis: getting the right dose [J].

Fiske, Joseph ;

Conley, Thomas ;

Sebastian, Shaji ;

Subramanian, Sreedhar .

FRONTLINE GASTROENTEROLOGY, 2020, 11 (06) :427-429

[4] Review article: applying pharmacokinetics to optimise dosing of anti-TNF biologics in acute severe ulcerative colitis [J].

Rosen, M. J. ;

Minar, P. ;

Vinks, A. A. .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 41 (11) :1094-1103

[5] Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update [J].

Schneider, Bryan J. ;

Naidoo, Jarushka ;

Santomasso, Bianca D. ;

Lacchetti, Christina ;

Adkins, Sherry ;

Anadkat, Milan ;

Atkins, Michael B. ;

Brassil, Kelly J. ;

Caterino, Jeffrey M. ;

Chau, Ian ;

Davies, Marianne J. ;

Ernstoff, Marc S. ;

Fecher, Leslie ;

Ghosh, Monalisa ;

Jaiyesimi, Ishmael ;

Mammen, Jennifer S. ;

Naing, Aung ;

Nastoupil, Loretta J. ;

Phillips, Tanyanika ;

Porter, Laura D. ;

Reichner, Cristina A. ;

Seigel, Carole ;

Song, Jung-Min ;

Spira, Alexander ;

Suarez-Almazor, Maria ;

Swami, Umang ;

Thompson, John A. ;

Vikas, Praveen ;

Wang, Yinghong ;

Weber, Jeffrey S. ;

Funchain, Pauline ;

Bollin, Kathryn .

JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (36) :4073-+

[6] Enterocolitis due to immune checkpoint inhibitors: a systematic review [J].

Soularue, Emilie ;

Lepage, Patricia ;

Colombel, Jean Frederic ;

Coutzac, Clelia ;

Faleck, David ;

Marthey, Lysiane ;

Collins, Michael ;

Chaput, Nathalie ;

Robert, Caroline ;

Carbonnel, Franck .

GUT, 2018, 67 (11) :2056-2067

[7] Management of Immunotherapy-Related Toxicities, Version 1.2020 Featured Updates to the NCCN Guidelines [J].

Thompson, John A. ;

Schneider, Bryan J. ;

Brahmer, Julie ;

Andrews, Stephanie ;

Armand, Philippe ;

Bhatia, Shailender ;

Budde, Lihua E. ;

Costa, Luciano ;

Davies, Marianne ;

Dunnington, David ;

Ernstoff, Marc S. ;

Frigault, Matthew ;

Kaffenberger, Benjamin H. ;

Lunning, Matthew ;

McGettigan, Suzanne ;

McPherson, Jordan ;

Mohindra, Nisha A. ;

Naidoo, Jarushka ;

Olszanski, Anthony J. ;

Oluwole, Olalekan ;

Patel, Sandip P. ;

Pennell, Nathan ;

Reddy, Sunil ;

Ryder, Mabel ;

Santomasso, Bianca ;

Shofer, Scott ;

Sosman, Jeffrey A. ;

Wang, Yinghong ;

Weight, Ryan M. ;

Johnson-Chilla, Alyse ;

Zuccarino-Catania, Griselda ;

Engh, Anita .

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2020, 18 (03) :230-241

[8] Incidence of immune checkpoint inhibitor-related colitis in solid tumor patients: A systematic review and meta-analysis [J].

Wang, Daniel Y. ;

Ye, Fei ;

Zhao, Shilin ;

Johnson, Douglas B. .

ONCOIMMUNOLOGY, 2017, 6 (10)

[9] Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis [J].

Wang, Yinghong ;

Wiesnoski, Diana H. ;

Helmink, Beth A. ;

Gopalakrishnan, Vancheswaran ;

Choi, Kati ;

DuPont, Hebert L. ;

Jiang, Zhi-Dong ;

Abu-Sbeih, Hamzah ;

Sanchez, Christopher A. ;

Chang, Chia-Chi ;

Parra, Edwin R. ;

Francisco-Cruz, Alejandro ;

Raju, Gottumukkala S. ;

Stroehlein, John R. ;

Campbell, Matthew T. ;

Gao, Jianjun ;

Subudhi, Sumit K. ;

Maru, Dipen M. ;

Blando, Jorge M. ;

Lazar, Alexander J. ;

Allison, James P. ;

Sharma, Padmanee ;

Tetzlaff, Michael T. ;

Wargo, Jennifer A. ;

Jenq, Robert R. .

NATURE MEDICINE, 2018, 24 (12) :1804-+

[10] Efficacy and safety of vedolizumab and infliximab treatment for immune-mediated diarrhea and colitis in patients with cancer: a two-center observational study [J].

Zou, Fangwen ;

Faleck, David ;

Thomas, Anusha ;

Harris, Jessica ;

Satish, Deepika ;

Wang, Xuemei ;

Charabaty, Aline ;

Ernstoff, Marc S. ;

Oliva, Isabella C. Glitza ;

Hanauer, Stephen ;

McQuade, Jennifer ;

Obeid, Michel ;

Shah, Amishi ;

Richards, David M. ;

Sharon, Elad ;

Wolchok, Jedd ;

Thompson, John ;

Wang, Yinghong .

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (11)

← 1 →